Ms Christina Binder

Medical University of Vienna, Vienna (Austria)

Membership: ESC Professional Member

Contributor content

Presentation

A novel SGLT-2 score to identify HFpEF patients who may benefit from SGLT-2 inhibitors

Presentation

Pericardial and pleural effusion in patients with cardiac amyloidosis

Presentation

Apical sparing in patients without cardiac amyloidosis

$Angiotensin converting enzyme 2 activity predicts outcome in heart failure with preserved ejection fraction$

Presentation

Angiotensin converting enzyme 2 activity predicts outcome in heart failure with preserved ejection fraction

$Renin activity is an independent predictor of outcome in patients with heart failure and preserved ejection fraction independent of RAAS blocker therapy$

Presentation

Renin activity is an independent predictor of outcome in patients with heart failure and preserved ejection fraction independent of RAAS blocker therapy

Presentation

Angiotensin based biomarkers predict outcome in HFpEF-patients

Presentation

Modes of death in cardiac amyloidosis

Presentation

Modes of death in cardiac amyloidosis

Presentation

Extracellular volume by cardiac magnetic resonance t1 mapping in cardiac amyloidosis: validation with endomyocardial biopsy

$Effect of persistent atrial fibrillation in heart failure patients with preserved ejection fraction - association with extracellular volume accumulation, invasive hemodynamics, and outcome$

Presentation

Effect of persistent atrial fibrillation in heart failure patients with preserved ejection fraction - association with extracellular volume accumulation, invasive hemodynamics, and outcome

Explore sponsored resources

Ms Christina Binder

Contributor content

A novel SGLT-2 score to identify HFpEF patients who may benefit from SGLT-2 inhibitors

Pericardial and pleural effusion in patients with cardiac amyloidosis

Apical sparing in patients without cardiac amyloidosis

Angiotensin converting enzyme 2 activity predicts outcome in heart failure with preserved ejection fraction

Renin activity is an independent predictor of outcome in patients with heart failure and preserved ejection fraction independent of RAAS blocker therapy

Angiotensin based biomarkers predict outcome in HFpEF-patients

Modes of death in cardiac amyloidosis

Modes of death in cardiac amyloidosis

Extracellular volume by cardiac magnetic resonance t1 mapping in cardiac amyloidosis: validation with endomyocardial biopsy

Effect of persistent atrial fibrillation in heart failure patients with preserved ejection fraction - association with extracellular volume accumulation, invasive hemodynamics, and outcome

ESC 365 is supported by